Screener
Generate Biomedicines, Inc. GENB Cash Flow Statement
| Q2 '26 | Q1 '26 | Q2 '25 | ||
|---|---|---|---|---|
| -$67.26M-18.5% | -$61.71M-39.3% | -$56.74M— | ||
| $3.2M-3.0% | $3.27M-4.1% | $3.3M— | ||
| $8.24M+50.1% | $6.4M+34.8% | $5.49M— | ||
| -$57.94M-18.9% | -$80.39M-51.2% | -$48.75M— | ||
| $933K+506% | $3.78M+403% | $154K— | ||
| —— | -$259.93M-444% | —— | ||
| —— | $378.89M+1,743% | —— | ||
| —— | $38.57M-10.1% | -$66.08M— | ||
| -$58.88M-20.4% | -$84.17M-56.1% | -$48.91M— |
FAQ
- How much cash does Generate Biomedicines, Inc. generate?
- Generate Biomedicines, Inc. (GENB) generated -$240.3M in operating cash flow over the trailing twelve months.
- What is Generate Biomedicines, Inc.'s free cash flow?
- After $5.6M of capital expenditures, Generate Biomedicines, Inc.'s free cash flow was -$245.9M over the trailing twelve months.
- Where does Generate Biomedicines, Inc.'s cash flow data come from?
- Every line is extracted from Generate Biomedicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
